Skip to content
Friday, May 23, 2025
Latest:
  • Enhancing the Accuracy of Plasma Protein Binding Assays
  • BioMarin Expands Enzyme Therapies Portfolio with Inozyme Acquisition
  • GSK Bolsters Gastrointestinal Cancer Portfolio with $1.15B Acquisition of IDRx
  • AstraZeneca Unveils $300 Million Cell Therapy Manufacturing Facility in Rockville, USA
  • Pharmaceutical Cold Chain Transportation Made Easy

Pharma Industry Review

Pharma Industry Review

  • Products
  • Companies
    • Find Suppliers
    • Press Releases
    • Downloads
    • Videos
    • Sponsored
  • Resources
  • Sectors
    • Preclinical Studies
    • Drug Discovery
    • Drug Development
    • Clinical Trials
    • Diagnostics
    • Manufacturing
    • Supply Chain
    • Regulatory
    • Artificial Intelligence (AI)
    • Digitalization
  • RESEARCH AREAS
    • Oncology
    • Immunology
    • Infectious Diseases
      • COVID-19
    • Neurology
      • Alzheimer’s
      • Parkinson’s
    • Respiratory
    • Fibrotic Diseases
    • Renal Diseases
    • Inflammatory Diseases
    • Vascular Diseases
    • Metabolic
  • Investment
    • Stocks
    • Deals
  • Projects

Clinical Trials

decorative gene editing
Clinical Trials Latest Rare Diseases 

Pfizer Reports Positive Results from Phase 3 Hemophilia B Gene Therapy Study

January 3, 2023January 3, 2023 Pharmaceutical Industry Editor

Pfizer Inc. (NYSE: PFE) announced in late December, positive top-line results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene

Read more
decorative
Clinical Trials COVID-19 Infectious Diseases Latest 

Apogenix’s Asunercept Shows efficacy in Phase II  COVID-19 Trial

October 20, 2022October 20, 2022 Pharmaceutical Industry Editor antibodies

Apogenix, a biopharmaceutical company developing next-gen immunotherapeutics, announced on Wednesday that asunercept showed statistically meaningful benefits for hospitalized COVID-19 patients

Read more
Clinical Trials DISEASES Infectious Diseases Latest 

Moderna Starts HIV Vaccine Trial that Uses Breakthrough mRNA Technology

February 2, 2022February 2, 2022 Pharmaceutical Industry Editor HIV, RNA

The first doses of an experimental HIV vaccine antigen have been provided in a clinical study at George Washington University

Read more
t-cell
Clinical Trials COVID-19 DISEASES Infectious Diseases Latest 

Emergex to Launch Phase I Trial for New T-Cell Priming COVID-19 Vaccine

November 20, 2021November 21, 2021 Pharmaceutical Industry Editor T-cell, vaccine development

A next-generation COVID-19 vaccine, developed by British biotech Emergex,  designed to prime T-Cells to rapidly remove viral-infected cells and offer

Read more
decorative
Clinical Trials DISEASES Neurology 

Phase 3 Data Support ADUHELM™ Ability to Reduce Alzheimer’s Disease Clinical Decline

November 16, 2021November 16, 2021 Pharmaceutical Industry Editor Alzheimer's, antibodies, monoclonal antibodies

New Phase 3 Data has shown a positive correlation between the human monoclonal antibody ADUHELM™ treatment effect on biomarkers and

Read more
decorative oral antiviral
Clinical Trials COVID-19 DISEASES Infectious Diseases Latest 

Pfizer’s COVID-19 Oral Antiviral Candidate 89% Effective in Phase 2/3 Study

November 6, 2021November 20, 2021 Pharmaceutical Industry Editor

The novel COVID-19 investigational oral antiviral treatment PAXLOVID™ (PF-07321332; ritonavir) by Pfizer, was found to reduce the risk of hospitalization

Read more
decorative
Clinical Trials DISEASES Oncology 

Rhizen Pharma Starts Dosing in Phase I/Ib Study of Novel PARP Inhibitor for Advanced Solid Tumors

November 3, 2021November 6, 2021 Pharmaceutical Industry Editor

Rhizen Pharmaceuticals has started dosing in a phase I/Ib trial to assess the efficiency of PARP inhibitor (RP12146) in advanced

Read more
Clinical Trials COVID-19 DISEASES Infectious Diseases Latest 

Valneva’s COVID-19 Vaccine Candidate Shows Positive Results in Phase 3 Trial

October 23, 2021March 26, 2023 Pharmaceutical Industry Editor vaccine development

French pharmaceutical company Valneva has reported positive results for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001 in the Phase 3

Read more
Clinical Trials COVID-19 DISEASES Infectious Diseases Latest 

Merck and Ridgeback’s Oral Antiviral Molnupiravir Can Halve COVID-19 Risk of Hospitalisation

October 2, 2021October 7, 2021 Pharmaceutical Industry Editor

Interim Analysis of Phase 3 Study shows Merck and Ridgeback’s investigational oral antiviral Molnupiravir has reduced the risk of hospitalization

Read more
Clinical Trials Oncology 

Phase 3 Results for Adjuvant Treatment with Merck’s KEYTRUDA® Show Superior RFS in Patients With Resected High-Risk Stage II Melanoma

September 19, 2021September 19, 2021 Pharmaceutical Industry Editor Adjuvants, monoclonal antibodies

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced on Saturday the first results from the

Read more
  • ← Previous
  • Next →
Ticker Tape by TradingView

DON’T MISS A THING


We don’t spam! Please read our Privacy Policy for more info.


Thanks! Finally, please check your inbox or spam folder to confirm your subscription.

Advertisement

Featured Company

    • SeNostic Logo upsc 768x439

    SeNostic

    Category: CRO, Drug Discovery and Recombinant Proteins
    Innovative Biologicals for Neuroscience Research Details Products Downloads Videos Press Releases Contact Details SeNostic provides innovative biologicals and in vitro diagnostic tools to advance neuroscience research and diagnostic tests. Specialising in high-quality recombinant proteins and state-of-the-art diagnostic platforms, SeNostic supports scientists, clinicians, and pharmaceutical companies in tackling neurodegenerative diseases like Alzheimer’s and Parkinson’s. Their products support early diagnosis, patient stratification Read more…

Featured Product

Assessment of Visual Performance in Mice
Neurology Preclinical Studies Products R&D 

In Vivo Assessment of Visual Performance in Mice

May 6, 2025May 6, 2025 Pharmaceutical Industry Editor

The unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for

LATEST

decorative pdf download icon
Case Studies Downloads Drug Discovery R&D 

Enhancing the Accuracy of Plasma Protein Binding Assays

May 19, 2025May 19, 2025 Pharmaceutical Industry Editor

Enhancing the Accuracy of Plasma Protein Binding (PPB) Assays for Challenging Drug Candidates An Inotiv Case Study Evaluating Sovicell’s TRANSIL

decpraitive
Deals Latest Rare Diseases 

BioMarin Expands Enzyme Therapies Portfolio with Inozyme Acquisition

May 19, 2025May 19, 2025 Pharmaceutical Industry Editor
decorative
Deals Latest Oncology 

GSK Bolsters Gastrointestinal Cancer Portfolio with $1.15B Acquisition of IDRx

May 15, 2025May 19, 2025 Pharmaceutical Industry Editor
decorative
Featured Immunology Manufacturing Oncology Projects R&D 

AstraZeneca Unveils $300 Million Cell Therapy Manufacturing Facility in Rockville, USA

May 12, 2025May 16, 2025 Pharmaceutical Industry Editor
decorative
Downloads Supply Chain White Papers 

Pharmaceutical Cold Chain Transportation Made Easy

May 8, 2025May 8, 2025 Pharmaceutical Industry Editor
Assessment of Visual Performance in Mice
Neurology Preclinical Studies Products R&D 

In Vivo Assessment of Visual Performance in Mice

May 6, 2025May 6, 2025 Pharmaceutical Industry Editor
decorative pdf download icon
Case Studies Downloads Immunology Manufacturing 

Lab Automation System Accelerates Immunoassay Development

May 6, 2025May 6, 2025 Pharmaceutical Industry Editor
decorative
Neurology Press Releases R&D 

Striatech Backs ARVO’s Rising Vision Scientist

April 28, 2025April 28, 2025 Pharmaceutical Industry Editor
decorative
Deals Latest Oncology 

Merck KGaA Agrees to Acquire SpringWorks for $3.9 Billion

April 28, 2025April 29, 2025 Pharmaceutical Industry Editor
decorative
Press Releases 

Striatech to Showcase Vision Research Innovations at ARVO 2025

April 28, 2025April 28, 2025 Pharmaceutical Industry Editor
The Versatile World of Camelid Antibodies: Exploring the Functions of VHH Domains
Press Releases 

The Versatile World of Camelid Antibodies: Exploring the Functions of VHH Domains

April 24, 2025April 28, 2025 Pharmaceutical Industry Editor
decorative
Diagnostics Latest Manufacturing Projects 

Roche to Invest $50B in US Pharma Expansion Set To Flip Trade Deficit

April 24, 2025May 12, 2025 Pharmaceutical Industry Editor
Automated Crystallization Imaging System
Products R&D 

Automated Crystallization Imaging System

April 10, 2025May 6, 2025 Pharmaceutical Industry Editor
decorative rna
Comments & Analysis Drug Discovery 

The Growing Importance of RNA Sequencing in Drug Discovery

April 4, 2025May 19, 2025 Pharmaceutical Industry Editor
Breakthroughs in Engineering Smaller and Safer Medical Devices
Manufacturing Press Releases 

Breakthroughs in Engineering Smaller and Safer Medical Devices

April 2, 2025April 28, 2025 Pharmaceutical Industry Editor
decorative
Cardiovascular Clinical Trials DISEASES Latest Vascular Diseases 

Lilly’s Lepodisiran Slashes Heart Disease Risk Factor by 94% in Phase 2 Trial

April 1, 2025April 29, 2025 Pharmaceutical Industry Editor
Lexicon Secures $1 Billion Deal with Novo Nordisk for Obesity Candidate
Deals Latest Metabolic 

Lexicon Secures $1 Billion Deal with Novo Nordisk for Obesity Candidate

March 29, 2025April 2, 2025 Pharmaceutical Industry Editor

Advertisement

About Us

Logo
Pharma Industry Review is here to provide you with the latest news, reviews and insights from the pharmaceutical industry so that you can take your business one step ahead.

About Us

  • Advertise
  • Contact Us
  • Editorial Standards
  • Terms & Conditions
  • Privacy Policy

Useful Links

  • Client Portal
  • Presentation Portal
  • Sectors
  • Projects
  • RSS Feed

RSS Feed

Copyright © 2025 Pharma Industry Review. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits, according to our Privacy Policy. You can enable the specific cookies from Settings or consent to the use of ALL the cookies.
.
Cookie settingsACCEPT ALL
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
__hssc30 minutesThis cookie is set by HubSpot. The purpose of the cookie is to keep track of sessions. This is used to determine if HubSpot should increment the session number and timestamps in the __hstc cookie. It contains the domain, viewCount (increments each pageView in a session), and session start timestamp.
na_id1 year 1 monthThis cookie is set by Addthis.com to enable sharing of links on social media platforms like Facebook and Twitter
na_rn1 monthThis cookie is used to recognize the visitor upon re-entry. This cookie allows to collect information on user behaviour and allows sharing function provided by Addthis.com
na_sc_e1 monthThis cookie is used to recognize the visitor upon re-entry. This cookie allows to collect information on user behaviour and allows sharing function provided by Addthis.com
na_sr1 monthThis cookie is set by Addthis.com. This cookie is used for sharing of links on social media platforms.
na_srp1 minuteThis cookie is used to recognize the visitor upon re-entry. This cookie allows to collect information on user behaviour and allows sharing function provided by Addthis.com
na_tc1 year 1 monthThis cookie is set by the provider Addthis. This cookie is used for social media sharing tracking service.
ouid1 year 1 monthThe cookie is set by Addthis which enables the content of the website to be shared across different networking and social sharing websites.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
CookieDurationDescription
d3 monthsThis cookie tracks anonymous information on how visitors use the website.
YSCsessionThis cookies is set by Youtube and is used to track the views of embedded videos.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
__gads1 year 24 daysThis cookie is set by Google and stored under the name dounleclick.com. This cookie is used to track how many times users see a particular advert which helps in measuring the success of the campaign and calculate the revenue generated by the campaign. These cookies can only be read from the domain that it is set on so it will not track any data while browsing through another sites.
__hstc1 year 24 daysThis cookie is set by Hubspot and is used for tracking visitors. It contains the domain, utk, initial timestamp (first visit), last timestamp (last visit), current timestamp (this visit), and session number (increments for each subsequent session).
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_gtag_UA_149839117_11 minuteGoogle uses this cookie to distinguish users.
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information on how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
hubspotutk1 year 24 daysThis cookie is used by HubSpot to keep track of the visitors to the website. This cookie is passed to Hubspot on form submission and used when deduplicating contacts.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
ab1 yearThis domain of this cookie is owned by agkn. The cookie is used for targeting and advertising purposes.
CMID1 yearThe cookie is set by CasaleMedia. The cookie is used to collect information about the usage behavior for targeted advertising.
CMPRO3 monthsThis cookie is set by Casalemedia and is used for targeted advertisement purposes.
CMPS3 monthsThis cookie is set by Casalemedia and is used for targeted advertisement purposes.
CMRUM31 yearThis cookie is set by Casalemedia and is used for targeted advertisement purposes.
CMST1 dayThe cookie is set by CasaleMedia. The cookie is used to collect information about the usage behavior for targeted advertising.
DSID1 hourThis cookie is setup by doubleclick.net. This cookie is used by Google to make advertising more engaging to users and are stored under doubleclick.net. It contains an encrypted unique ID.
id1 year 1 monthThe main purpose of this cookie is targeting and advertising. It is used to create a profile of the user's interest and to show relevant ads on their site. This Cookie is set by DoubleClick which is owned by Google.
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
KADUSERCOOKIE3 monthsThe cookie is set by pubmatic.com for identifying the visitors' website or device from which they visit PubMatic's partners' website.
KTPCACOOKIE1 dayThis cookie is set by pubmatic.com for the purpose of checking if third-party cookies are enabled on the user's website.
mc1 year 1 monthThis cookie is associated with Quantserve to track anonymously how a user interact with the website.
mdata1 year 1 monthThe domain of this cookie is owned by Media Innovation group. This cookie registers a unique ID used to identify a visitor on their revisit inorder to serve them targeted ads.
ov1 year 1 monthThis cookie is set by the provider mookie1.com. This cookie is used for serving the user with relevant content and advertisement.
pxrc2 monthsThe purpose of the cookie is to identify a visitor to serve relevant advertisement.
rlas31 yearThe cookie is set by rlcdn.com. The cookie is used to serve relevant ads to the visitor as well as limit the time the visitor sees an and also measure the effectiveness of the campaign.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
uid1 year 1 monthThis cookie is used to measure the number and behavior of the visitors to the website anonymously. The data includes the number of visits, average duration of the visit on the website, pages visited, etc. for the purpose of better understanding user preferences for targeted advertisments.
uuid3 monthsTo optimize ad relevance by collecting visitor data from multiple websites such as what pages have been loaded.
uuid23 monthsThis cookies is set by AppNexus. The cookies stores information that helps in distinguishing between devices and browsers. This information us used to select advertisements served by the platform and assess the performance of the advertisement and attribute payment for those advertisements.
VISITOR_INFO1_LIVE5 months 27 daysThis cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
anj3 monthsNo description
CONSENT16 years 9 months 12 days 8 hoursNo description
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others1 yearNo description
GoogleAdServingTestsessionNo description
i1 yearThe purpose of the cookie is not known yet.
u1 yearThe purpose of this cookie is targeting and marketing.The domain of this cookie is related with a company called Bombora in USA.
SAVE & ACCEPT
Powered by CookieYes Logo